Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: XVIVO Presents Strategic Focus Areas For 2022-2026

Sept 23 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * XVIVO CAPITAL MARKETS DAY PRESENTS STRATEGIC FOCUS AREAS
FOR
2022-2026
    * XVIVOS AMBITION IS TO REACH AN EBIT-MARGIN OF 20 % AND AN
EBITDA-MARGIN OF 30 % DURING STRATEGY PERIOD
    * IN 2026, ABDOMINAL REVENUE IS EXPECTED TO BE OF EQUAL SIZE
AS
THORACIC REVENUE
    * WILL CONTINUE TO BUILD ON ITS WORLD LEADING POSITION IN
LUNG
TRANSPLANTATION AND DEVELOP OFFERING TO COVER ALL FOUR MAJOR
ORGANS: LUNG, HEART, KIDNEY AND LIVER

Source text for Eikon:  ID:nMFN7TQ4VQ 
Further company coverage:  XVIVO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Xvivo Perfusion AB

See all news